Press Releases about Annovis Bio Inc![]() From Annovis Bio Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() From Annovis Bio Inc.
Via GlobeNewswire
![]() ![]() ![]() ![]()
Annovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s Patients
November 02, 2023
From Annovis Bio
Via Business Wire
![]()
Annovis Bio Announces Pricing of $7.5 Million Public Offering
October 31, 2023
From Annovis Bio, Inc.
Via Business Wire
![]()
Annovis Bio Announces Launch of Proposed Public Offering
October 30, 2023
From Annovis Bio, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() From Annovis Bio, Inc.
Via Business Wire
![]()
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
January 25, 2022
Via Newsfile
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|